Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.45 |
| ▸ | TSHR | P16473 | 4/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | TP53 | P04637 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.38 |
| ▸ | GSK3A | P49840 | 1/20 | 0.38 |
| ▸ | GSK3B | P49841 | 1/20 | 0.38 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.38 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | AHR | P35869 | 1/20 | 0.36 |
| ▸ | MAP2K1 | Q02750 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28338346 | 0.85 | GPR35 (0.42) | ALDH1A1TSHRCYP3A4HPGDHSD17B10 | |
| SCHEMBL28031894 | 0.85 | ALDH1A1 (0.38) | ALDH1A1TSHRCYP3A4HPGDHSD17B10 | |
| SCHEMBL2947899 | 0.83 | ALDH1A1 (0.36) | ALDH1A1TSHRCYP3A4HPGDHSD17B10 | |
| SCHEMBL15129217 | 0.83 | TRPV4 (0.46) | ALDH1A1TSHRCYP3A4HPGDHSD17B10 | |
| SCHEMBL8968834 | 0.83 | GSK3A (0.40) | ALDH1A1TSHRCYP3A4HPGDHSD17B10 | |
| SCHEMBL967389 | 0.83 | KDM4E (0.47) | ALDH1A1TSHRCYP3A4HPGDHSD17B10 | |
| SCHEMBL15850516 | 0.80 | VCAM1 (0.40) | ALDH1A1TSHRCYP3A4HPGDTP53 | |
| SCHEMBL1900659 | 0.78 | CYP3A4 (0.50) | ALDH1A1CYP3A4HPGDHSD17B10TP53 | |
| SCHEMBL21305046 | 0.78 | ALDH1A1 (0.38) | ALDH1A1CYP3A4HPGDTP53MEN1 | |
| SCHEMBL21064821 | 0.78 | TRPV4 (0.41) | ALDH1A1CYP3A4HPGDHSD17B10TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111499540-B | Method for preparing 2,4,6-trichlorobenzonitrile by ammoxidation method, special catalyst and preparation method | 中南民族大学 | 2022-09-27 | — | — | CN | claimed |
| CN-113024412-A | Preparation method of 2,4, 6-trichlorobenzonitrile | 上海立科化学科技有限公司 | 2021-06-25 | — | — | CN | claimed |
| CN-111499540-A | Method for preparing 2,4,6-trichlorobenzonitrile by ammoxidation method, special catalyst and preparation method | 中南民族大学 | 2020-08-07 | — | — | CN | claimed |
| JP-60023358-A | — | — | None | — | — | JP | disclosed |
| US-20250242338-A1 | IRON PHOSPHIDE NANOPARTICLES, AND COMPOSITE BODY AND REDUCTION CATALYST EACH CONTAINING SAME | OSAKA UNIVERSITY (JP) | 2025-07-31 | — | — | US | disclosed |
| EP-4509462-A1 | IRON PHOSPHIDE NANOPARTICLES, AND COMPOSITE BODY AND REDUCTION CATALYST EACH CONTAINING SAME | OSAKA UNIVERSITY (JP) | 2025-02-19 | — | — | EP | disclosed |
| WO-2023200015-A1 | IRON PHOSPHIDE NANOPARTICLES, AND COMPOSITE BODY AND REDUCTION CATALYST EACH CONTAINING SAME | 国立大学法人大阪大学 | 2023-10-19 | — | — | WO | disclosed |
| CN-111499540-B | Method for preparing 2,4,6-trichlorobenzonitrile by ammoxidation method, special catalyst and preparation method | 中南民族大学 | 2022-09-27 | — | — | CN | disclosed |
| CN-111499540-B | Method for preparing 2,4,6-trichlorobenzonitrile by ammoxidation method, special catalyst and preparation method | 中南民族大学 | 2022-09-27 | — | — | CN | disclosed |
| CN-111499540-B | Method for preparing 2,4,6-trichlorobenzonitrile by ammoxidation method, special catalyst and preparation method | 中南民族大学 | 2022-09-27 | — | — | CN | disclosed |
| CN-111004149-B | Method for preparing polyfluorobenzonitrile by catalytic fluorination of polychlorinated benzonitrile | 大连奇凯医药科技有限公司 | 2022-06-07 | — | — | CN | disclosed |
| EP-1015402-A1 | METHOD FOR PRODUCING COMPOUNDS CONTAINING FLUORINE, IN PARTICULAR FLUOROBENZALDHYDES AND FLUOROBENZONITRILES | Aventis Research & Technologies GmbH & Co. KG (DE) | 2000-07-05 | — | — | EP | disclosed |
| WO-1999011588-A1 | METHOD FOR PRODUCING COMPOUNDS CONTAINING FLUORINE, IN PARTICULAR FLUOROBENZALDHYDES AND FLUOROBENZONITRILES | AVENTIS RESEARCH & TECHNOLOGIES GMBH & CO. KG (DE) | 1999-03-11 | — | — | WO | disclosed |
| US-5795905-A | 3-AMINO-5-PHENYL-1,2,4-TRIAZOLES | NEUROCRINE BIOSCIENCES, INC. (US) | 1998-08-18 | — | — | US | disclosed |
| EP-0846108-A1 | AMINO-SUBSTITUTED THIADIAZOLES, PYRIMIDINES, TRIAZINES OR TRIAZOLES USEFUL AS CTF RECEPTOR ANTAGONISTS | NEUROCRINE BIOSCIENCES, INC. (US) | 1998-06-10 | — | — | EP | disclosed |
| WO-1996039400-A1 | AMINO-SUBSTITUTED THIADIAZOLES, PYRIMIDINES, TRIAZINES OR TRIAZOLES USEFUL AS CTF RECEPTOR ANTAGONISTS | NEUROCRINE BIOSCIENCES, INC. (US) | 1996-12-12 | — | — | WO | disclosed |
| EP-0141228-B1 | A PROCESS FOR PRODUCING POLYCHLOROBENZONITRILE | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1988-01-07 | — | — | EP | disclosed |
| US-4530797-A | Ammoxidation of toluene derivative having chlorine in positions 2 and 6 in presence of catalyst | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1985-07-23 | — | — | US | disclosed |
| EP-0141228-A1 | A process for producing polychlorobenzonitrile | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1985-05-15 | — | — | EP | disclosed |
| JP-S6023358-A | 2,4,6-TRIFLUOROBENZONITRILE | ISHIHARA SANGYO KAISHA LTD | 1985-02-05 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250242338-A1 | IRON PHOSPHIDE NANOPARTICLES, AND COMPOSITE BODY AND REDUCTION CATALYST EACH CONTAINING SAME | FECH, PI4K2A, PHOSPHO1 | ALDH1A1 4269/4885TSHR 2770/4885CYP3A4 3109/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.